Hogan Lovells Moscow Life Sciences team secures major win in a precedent patent case for Novartis against a generic producer in Russia

Published date05 February 2018
Law FirmHogan Lovells
AuthorNatalia Gulyaeva
Subject MatterPatents,Life Sciences,Prescription Drugs,Generic Drugs,Novartis,Patent Litigation,Pharmaceutical Patents,Patent Infringement,Russia,Injunctive Relief,Commercial Marketing,Intellectual Property Protection,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT